IntelliGenome is a CRISPR molecular diagnostic start-up based in Houston, Texas. The company was founded in July 2022 with a commitment to commercialize an innovative CRISPR detection platform technology. Our mission is to revolutionize the field of disease diagnostics by harnessing the power of CRISPR technology.

Our innovative platform enables direct measurement and quantification of active disease elements, providing healthcare providers with critical information for treatment monitoring and optimizing drug efficacy.​​

Biotechnology

Health Diagnostics

Life Sciences

Intelligenome

Intelligenome's headquarters in Houston, United States

Description

People (4)

Wilson Zhang M.D. Msc

Yuanyuan Kang

Simon Huo

Tristine Jackson

Jobs